{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:23:50Z","timestamp":1785842630081,"version":"3.56.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH\/NCI MD Anderson Uterine Cancer SPORE"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.ygyno.2011.10.025","type":"journal-article","created":{"date-parts":[[2011,10,29]],"date-time":"2011-10-29T01:44:45Z","timestamp":1319852685000},"page":"270-275","source":"Crossref","is-referenced-by-count":76,"title":["Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer"],"prefix":"10.1016","volume":"124","author":[{"given":"Eleftheria","family":"Kalogera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Scholler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecelia","family":"Powless","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronny","family":"Drapkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Wen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Podratz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Urban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean C.","family":"Dowdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2011.10.025_bb0005","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/canjclin.40.1.9","article-title":"Cancer statistics, 1990","volume":"40","author":"Silverberg","year":"1990","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0015","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","article-title":"Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies","volume":"371","author":"Renehan","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0020","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ygyno.2006.02.011","article-title":"Follow-up after primary therapy for endometrial cancer: a systematic review","volume":"101","author":"Fung-Kee-Fung","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0025","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1046\/j.1525-1438.2002.01007.x","article-title":"Tissue and serum CA125 expression in endometrial cancer","volume":"12","author":"Ginath","year":"2002","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0030","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1006\/gyno.2002.6664","article-title":"Can a preoperative CA 125 level be a criterion for full pelvic lymphadenectomy in surgical staging of endometrial cancer?","volume":"86","author":"Hsieh","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0035","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0029-7844(97)00286-X","article-title":"Value of preoperative CA 125 level in the management of uterine cancer and prediction of clinical outcome","volume":"90","author":"Sood","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0040","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1006\/gyno.1996.4545","article-title":"Significance of a single CA 125 assay combined with ultrasound in the early detection of ovarian and endometrial cancer","volume":"64","author":"Vuento","year":"1997","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0045","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/0002-9378(86)90358-3","article-title":"CA 125: a useful marker in endometrial carcinoma","volume":"155","author":"Duk","year":"1986","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0050","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0002-9378(84)90444-7","article-title":"Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervix","volume":"148","author":"Niloff","year":"1984","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0055","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/bjc.1989.329","article-title":"The clinical correlates of serum CA125 in 169 patients with epithelial ovarian carcinoma","volume":"60","author":"Hawkins","year":"1989","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0060","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1200\/JCO.2001.19.20.4054","article-title":"Use of CA-125 to define progression of ovarian cancer in patients with persistently elevated levels","volume":"19","author":"Rustin","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0065","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/oxfordjournals.annonc.a010602","article-title":"Defining progression of ovarian carcinoma during follow-up according to CA 125: a North Thames Ovary Group Study","volume":"7","author":"Rustin","year":"1996","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0070","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2605.1990.tb00972.x","article-title":"Cloning and analysis of mRNAs expressed specifically in the human epididymis","volume":"13","author":"Kirchhoff","year":"1990","journal-title":"Int J Androl"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0075","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1095\/biolreprod45.2.350","article-title":"A major human epididymis-specific cDNA encodes a protein with sequence homology to extracellular proteinase inhibitors","volume":"45","author":"Kirchhoff","year":"1991","journal-title":"Biol Reprod"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0080","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.bbrc.2005.05.125","article-title":"The evolution of a genetic locus encoding small serine proteinase inhibitors","volume":"333","author":"Clauss","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0085","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1465-9921-7-61","article-title":"WFDC2 (HE4): a potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung","volume":"7","author":"Bingle","year":"2006","journal-title":"Respir Res"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0090","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1470-2045(06)70579-4","article-title":"Proteins with whey-acidic-protein motifs and cancer","volume":"7","author":"Bouchard","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0095","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.1158\/0008-5472.CAN-05-0108","article-title":"Using a xenograft model of human breast cancer metastasis to find genes associated with clinically aggressive disease","volume":"65","author":"Kluger","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0100","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/09629350210304","article-title":"The presence of elafin, SLPI, IL1-RA and STNFalpha RI in head and neck squamous cell carcinomas and their relation to the degree of tumour differentiation","volume":"11","author":"Westin","year":"2002","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0105","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.bbamcr.2005.07.006","article-title":"Suppression of macrophage responses to bacterial lipopolysaccharide (LPS) by secretory leukocyte protease inhibitor (SLPI) is independent of its anti-protease function","volume":"1745","author":"Yang","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0110","first-page":"495","article-title":"Immunohistochemical expression of SKALP\/elafin in squamous cell carcinoma of human lung","volume":"9","author":"Yoshida","year":"2002","journal-title":"Oncol Rep"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0115","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/modpathol.3800612","article-title":"Comprehensive analysis of HE4 expression in normal and malignant human tissues","volume":"19","author":"Galgano","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0120","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-04-3924","article-title":"Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas","volume":"65","author":"Drapkin","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0125","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.1091\/mbc.E03-05-0279","article-title":"Gene expression patterns in ovarian carcinomas","volume":"14","author":"Schaner","year":"2003","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0130","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-0-387-68969-2_2","article-title":"SMRP and HE4 as biomarkers for ovarian carcinoma when used alone and in combination with CA125 and\/or each other","volume":"622","author":"Hellstrom","year":"2008","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0135","first-page":"3695","article-title":"The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma","volume":"63","author":"Hellstrom","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0140","first-page":"6281","article-title":"Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer","volume":"60","author":"Hough","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0145","first-page":"5007","article-title":"Identification by cDNA microarray of genes involved in ovarian carcinogenesis","volume":"60","author":"Ono","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0150","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0378-1119(99)00342-X","article-title":"Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas","volume":"238","author":"Schummer","year":"1999","journal-title":"Gene"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0155","first-page":"5895","article-title":"Genetic analysis of early- versus late-stage ovarian tumors","volume":"61","author":"Shridhar","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0160","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1073\/pnas.98.3.1176","article-title":"Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer","volume":"98","author":"Welsh","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0165","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ygyno.2007.10.017","article-title":"The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass","volume":"108","author":"Moore","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0170","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1074\/mcp.M600378-MCP200","article-title":"Endometrial carcinoma biomarker discovery and verification using differentially tagged clinical samples with multidimensional liquid chromatography and tandem mass spectrometry","volume":"6","author":"DeSouza","year":"2007","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0175","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/pr0700798","article-title":"Identification of candidate biomarker proteins released by human endometrial and cervical cancer cells using two-dimensional liquid chromatography\/tandem mass spectrometry","volume":"6","author":"Li","year":"2007","journal-title":"J Proteome Res"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0180","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ygyno.2008.04.002","article-title":"Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus","volume":"110","author":"Moore","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0185","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/bjc.2011.109","article-title":"Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients","volume":"104","author":"Bignotti","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0190","series-title":"Podratz KC","author":"Bakkum-Gamez","year":"2011"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0195","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1158\/1078-0432.CCR-07-1442","article-title":"Use of yeast-secreted in vivo biotinylated recombinant antibodies (Biobodies) in bead-based ELISA","volume":"14","author":"Scholler","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0200","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1006\/gyno.1997.4620","article-title":"Is OVX1 a suitable marker for endometrial cancer?","volume":"65","author":"Beck","year":"1997","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0205","first-page":"315","article-title":"The value of serum CA 125 and association CA 125\/CA 19\u20139 in endometrial carcinoma","volume":"20","author":"Cherchi","year":"1999","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0210","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/jcp.49.12.967","article-title":"Serum and tissue measurements of CA72-4 in patients with endometrial carcinoma","volume":"49","author":"Hareyama","year":"1996","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0215","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/S0002-9378(96)70678-6","article-title":"Preoperative evaluation of macrophage colony-stimulating factor levels in patients with endometrial cancer","volume":"174","author":"Olt","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0220","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/gyno.1994.1217","article-title":"Combined assay of serum levels of CA125 and CA19-9 in endometrial carcinoma","volume":"54","author":"Takeshima","year":"1994","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0225","first-page":"4779","article-title":"HE4 expression can be associated with lymph node metastases and disease-free survival in breast cancer","volume":"30","author":"Kamei","year":"2010","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0230","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.ygyno.2005.03.008","article-title":"Predictors of vaginal relapse in stage I endometrial cancer","volume":"97","author":"Mariani","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0235","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1006\/gyno.1999.5688","article-title":"Potential therapeutic role of para-aortic lymphadenectomy in node-positive endometrial cancer","volume":"76","author":"Mariani","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0240","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1006\/gyno.2001.6550","article-title":"Predictors of lymphatic failure in endometrial cancer","volume":"84","author":"Mariani","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0245","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1067\/mob.2000.107335","article-title":"Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary?","volume":"182","author":"Mariani","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0250","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1006\/gyno.2002.6836","article-title":"Surgical stage I endometrial cancer: predictors of distant failure and death","volume":"87","author":"Mariani","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0255","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/jnci\/djn397","article-title":"Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial","volume":"100","author":"Benedetti Panici","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0260","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(08)61766-3","article-title":"Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study","volume":"373","author":"Kitchener","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0265","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ygyno.2004.01.031","article-title":"The role of MRI in the conservative management of endometrial cancer","volume":"93","author":"Ben-Shachar","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0270","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ygyno.2005.12.028","article-title":"MR imaging in endometrial carcinoma as a diagnostic tool for the absence of myometrial invasion","volume":"102","author":"Nakao","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.10.025_bb0275","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S1701-2163(16)34657-6","article-title":"Preoperative CA 125 tumour marker in endometrial cancer: correlation with advanced stage disease","volume":"32","author":"Sebastianelli","year":"2010","journal-title":"J Obstet Gynaecol Can"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825811008675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825811008675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T19:50:38Z","timestamp":1560887438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825811008675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0090825811008675"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2011.10.025","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}